Galmed pharmaceuticals announces upcoming publication in jhep reports of new data supporting aramchol's novel anti-fibrotic mechanism of action

Tel aviv, israel, jan. 26, 2021 /prnewswire/ -- galmed pharmaceuticals ltd. (nasdaq: glmd) ("galmed" or the "company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced upcoming publication of a paper entitled "aramchol...

GLMD Ratings Summary

GLMD Quant Ranking